UBC Faculty Research and Publications

Do Statins have a Role in Primary Prevention? Therapeutics Initiative (University of British Columbia)

Description

Therapeutics Letter 48 considers whether statins have a role in primary prevention. Conclusions: If cardiovascular serious adverse events are viewed in isolation, 71 primary prevention patients with cardiovascular risk factors have to be treated with a statin for 3 to 5 years to prevent one myocardial infarction or stroke. This cardiovascular benefit is not reflected in 2 measures of overall health impact, total mortality and total serious adverse events. Therefore, statins have not been shown to provide an overall health benefit in primary prevention trials.

Item Citations and Data

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International